Inter- and intraobserver variability in the evaluation of dynamic breast cancer MRI

被引:33
作者
Beresford, Mark J.
Padhani, Anwar R.
Taylor, N. Jane
Ah-See, Mei-Lin
Stirling, J. James
Makris, Andreas
d'Arcy, James A.
Collins, David J.
机构
[1] Mt Vernon Hosp, Paul Strickland Scanner Ctr, Northwood HA6 2RN, Middx, England
[2] Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England
[3] Royal Marsden Hosp, CRUK Clin MR Res Grp, Sutton, Surrey, England
关键词
DCE-MRI; observer variability; dynamic MRI; breast cancer; observer experience;
D O I
10.1002/jmri.20768
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To quantify variations within and between observers ascribable to manual region of interest (ROI) placement in patients with breast cancer undergoing dynamic MRI. Materials and Methods: Expert and nonexpert observers independently outlined tumor ROIs on 30 dynamic T-1-weighted (T1W) MRI scans on five occasions over two months. Lesion size (number of pixels) and kinetic parameter estimates, including the transfer constant (K-trans), were calculated for each ROI placement. Inter- and intraobserver variability was assessed with respect to the interval between drawings, lesion morphology, and observer experience. Results: For the nonexpert, the variability reduced with decreasing time intervals between ROI drawings (the coefficient of variance (wCV) values at two months, two weeks, one day, and same-day time intervals were respectively 11.6%, 10.7%, 4.8%, and 2.6% for lesion size, and 8.9%, 9.7%, 6.7%, and 3.2% for K-trans). For the expert observer, the variability was smaller overall and more constant, but improved for same-day ROI placements (region size wCV: 7.5%,6.2%,7.1%, and 3.7%; K-trans wCV: 5.4%,5.3%,5.6%, and 4.5%). Conclusion: Significant observer variability in manual ROI placement occurs in dynamic MRI of breast cancer. For serial patient studies, ROI placements should be outlined at the same sitting to minimize observer error.
引用
收藏
页码:1316 / 1325
页数:10
相关论文
共 24 条
[1]  
AHSEE ML, 2004, P ASS, V23, P22
[2]  
AHSEE MW, 2004, ISMRM WORKSH MANCH U
[3]   Measuring agreement in method comparison studies [J].
Bland, JM ;
Altman, DG .
STATISTICAL METHODS IN MEDICAL RESEARCH, 1999, 8 (02) :135-160
[4]   Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging [J].
Choyke, PL ;
Dwyer, AJ ;
Knopp, MV .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2003, 17 (05) :509-520
[5]   Dynamic magnetic resonance imaging of tumor perfusion [J].
Collins, DJ ;
Padhani, AR .
IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE, 2004, 23 (05) :65-83
[6]   Informatics in radiology (infoRAD) - Magnetic Resonance Imaging Workbench: Analysis and visualization of dynamic contrast-enhanced MR imaging data [J].
d'Arcy, James A. ;
Collins, David J. ;
Padhani, Anwar R. ;
Walker-Samuel, Simon ;
Suckling, John ;
Leach, Martin O. .
RADIOGRAPHICS, 2006, 26 (02) :621-632
[7]  
DeVries AF, 2001, CANCER RES, V61, P2513
[8]   MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer [J].
Esserman, L ;
Kaplan, E ;
Partridge, S ;
Tripathy, D ;
Rugo, H ;
Park, J ;
Hwang, S ;
Kuerer, H ;
Sudilovsky, D ;
Lu, Y ;
Hylton, N .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (06) :549-559
[9]   Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging [J].
Galbraith, SM ;
Maxwell, RJ ;
Lodge, MA ;
Tozer, GM ;
Wilson, J ;
Taylor, NJ ;
Stirling, JJ ;
Sena, L ;
Padhani, AR ;
Rustin, GJS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2831-2842
[10]   Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer [J].
George, ML ;
Dzik-Jurasz, ASK ;
Padhani, AR ;
Brown, G ;
Tait, DM ;
Eccles, SA ;
Swift, RI .
BRITISH JOURNAL OF SURGERY, 2001, 88 (12) :1628-1636